Can Raloxifene Reduce the Risk of Breast Cancer? Yes, Raloxifene has been shown to help reduce the risk of certain types of breast cancer, particularly invasive estrogen receptor-positive (ER+) breast cancer in postmenopausal women. It works by acting as a selective estrogen receptor modulator (SERM) — meaning it blocks the effects of estrogen in breast tissue, which can slow or prevent the growth of cancer cells that rely on this hormone. Originally developed to treat and prevent osteoporosis. visit : https://www.dosepharmacy.com/ralista-60mg-tablet
Synes godt om
Kommentar
Del
